Electrophysiological effects of glucose-insulin-potassium on sinus node function in patients with and without sinus node dysfunction.
The electrophysiological effects of glucose (100 g)-insulin (20 U)-potassium (10 mmol X litre-1) infusion (GIK) on three parameters of sinus node function were studied in 14 control subjects (mean age 53 +/- 14 yr) and 11 patients (mean age 50 +/- 17 yr) with sinus node dysfunction (SND). In a first series of experiments the response to GIK was examined in nine control and 11 SND patients. Following GIK, the mean spontaneous cycle length decreased by 17% (671 to 560 ms; P less than 0.01) in the control group and by 33% (1066 to 715 ms; P less than 0.001) in the SND patients; this difference between both groups was statistically significant (P less than 0.01). In the control group mean corrected sinus node recovery time (CRST) and calculated sinoatrial conduction time (SACT; n = 6) were not significantly altered after GIK. In SND patients GIK decreased the mean value of CSRT by 40% (693 to 416 ms; P less than 0.05) and of calculated SACT (n = 6) by 27% (130 to 95 ms; P less than 0.05); prolonged secondary pauses following termination of rapid atrial pacing in SND patients were also shortened. In a second series of experiments, mannitol (100 g, iv) was administered in five control patients but had no significant effect on the electrophysiological parameters tested. Plasma levels of glucose were significantly increased, by 500% (P less than 0.01), after GIK; plasma potassium and sodium concentrations decreased by 7 and 5% (P less than 0.05). The results indicate that GIK had a beneficial effect on sinus node dysfunction.
D000328:Adult; D000368:Aged; D002304:Cardiac Pacing, Artificial; D004338:Drug Combinations; D004562:Electrocardiography; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006327:Heart Block / Q000503:physiopathology*; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D008353:Mannitol / Q000494:pharmacology; D008875:Middle Aged; D011188:Potassium / Q000494:pharmacology*; D012848:Sinoatrial Block / Q000503:physiopathology*; D012849:Sinoatrial Node / Q000187:drug effects* / Q000503:physiopathology
D004338:Drug Combinations; D007328:Insulin; D008353:Mannitol; D005947:Glucose; D011188:Potassium